AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Al-Ghnaniem, R.
Right arrow Articles by Pufulete, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Al-Ghnaniem, R.
Right arrow Articles by Pufulete, M.
Agricola
Right arrow Articles by Al-Ghnaniem, R.
Right arrow Articles by Pufulete, M.
American Journal of Clinical Nutrition, Vol. 86, No. 4, 1064-1072, October 2007
© 2007 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Methylation of estrogen receptor {alpha} and mutL homolog 1 in normal colonic mucosa: association with folate and vitamin B-12 status in subjects with and without colorectal neoplasia1,2

Reyad Al-Ghnaniem, Jennifer Peters, Roberta Foresti, Nigel Heaton and Maria Pufulete

1 From the Nutritional Sciences Research Division, King's College London, London, United Kingdom

Background: Greater promoter methylation in some tumor-suppressor genes underlies most sporadic colorectal cancers and increases with age in the colon.

Objective: We tested the hypothesis that biomarkers of folate and vitamin B-12 status are associated with estrogen receptor {alpha} (ER{alpha}) and mutL homolog 1 (MLH1) promoter methylation in subjects with and without neoplasia.

Design: Biopsies of normal-appearing colorectal mucosa from 156 subjects with and without colorectal neoplasia (disease free, n = 76; cancer, n = 28; adenoma, n = 35; hyperplastic polyps, n = 17) were obtained at colonoscopy and used to evaluate methylation in 7 CpG sites in the ER{alpha} promoter and 13 CpG sites in the MLH1 promoter. Blood samples were obtained for the measurement of serum and red cell folate, serum vitamin B-12, and plasma homocysteine concentrations. Methylation indexes were generated to reflect an average methylation value across all CpG dinucleotides in both ER{alpha} and MLH1.

Results: The methylation indexes for ER{alpha} and MLH1 generally were significantly (P < 0.05) higher in subjects with neoplasia than in disease-free subjects. The ER{alpha} methylation index correlated negatively with serum vitamin B-12 (r = –0.239, P = 0.003) and positively with plasma homocysteine (r = 0.188, P = 0.021). Disease status (P < 0.005), age (P < 0.001), and serum vitamin B-12 concentrations (P = 0.006) were independent determinants of ER{alpha} promoter methylation. Serum and red cell folate concentrations had no influence on ER{alpha} promoter methylation.

Conclusion: Serum vitamin B-12 but not folate status may be associated with ER{alpha} promoter methylation in normal-appearing colorectal mucosa.

Key Words: Folate • vitamin B-12 • homocysteine • DNA methylation • estrogen receptor {alpha} • ER{alpha} • mutL homolog 1 • MLH1 • colorectal cancer • colorectal adenoma • hyperplastic polyps




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. S. Ally, R. Al-Ghnaniem, and M. Pufulete
The Relationship between Gene-Specific DNA Methylation in Leukocytes and Normal Colorectal Mucosa in Subjects with and without Colorectal Tumors
Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 922 - 928.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The American Society for Nutrition